Endophthalmitis: potential benefits of repeated intravitreal injections of antibiotics.
Hui
M
M
Lam
W H
WH
Ho
W H
WH
Chan
C Y
CY
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D016957:Burkholderia pseudomallei / Q000187:drug effects*; D002442:Ceftazidime / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D009877:Endophthalmitis / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007267:Injections; D008554:Melioidosis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D016896:Treatment Outcome; D014822:Vitreous Body
D000900:Anti-Bacterial Agents; D002442:Ceftazidime